Life
Briefing: Light-activated medicines may cut side effects: How a switchable beta blocker works
Strategic angle: Research in photopharmacology aims to develop drugs that can be switched on and off with light, potentially reducing side effects.
editorial-staff
1 min read
Updated 23 days ago
Recent studies in photopharmacology focus on developing switchable beta blockers that can be activated or deactivated by specific wavelengths of light.
This innovative approach aims to improve the precision of medication delivery, allowing for targeted treatments that minimize adverse effects.
The implications for healthcare infrastructure are significant, as this technology could lead to more efficient drug administration protocols and better patient outcomes.